-
1
-
-
0035496220
-
The development of androgen-independent prostate cancer
-
Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev 2001;1:34-45.
-
(2001)
Nat Rev
, vol.1
, pp. 34-45
-
-
Feldman, B.J.1
Feldman, D.2
-
2
-
-
0035740251
-
Contribution of the androgen receptor to prostate cancer predisposition and progression
-
Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 2001;20:207-223.
-
(2001)
Cancer Metastasis Rev
, vol.20
, pp. 207-223
-
-
Buchanan, G.1
Irvine, R.A.2
Coetzee, G.A.3
Tilley, W.D.4
-
3
-
-
0009421291
-
Androgen receptor structure and function in prostate cancer
-
Li JJ, Darling JR, Li SA, editors. New York: Springer-Verlag
-
Buchanan G, Tilley WD. Androgen receptor structure and function in prostate cancer. In: Li JJ, Darling JR, Li SA, editors. Hormonal carcinogehesis III. New York: Springer-Verlag; 2000. pp 333-341.
-
(2000)
Hormonal Carcinogehesis III
, pp. 333-341
-
-
Buchanan, G.1
Tilley, W.D.2
-
4
-
-
0031028190
-
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications
-
Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate 1997;30:136-142.
-
(1997)
Prostate
, vol.30
, pp. 136-142
-
-
Webber, M.M.1
Bello, D.2
Quader, S.3
-
5
-
-
0031036928
-
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 2. Tumorigenic cell lines
-
Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 1997;30:58-64.
-
(1997)
Prostate
, vol.30
, pp. 58-64
-
-
Webber, M.M.1
Bello, D.2
Quader, S.3
-
6
-
-
0030472709
-
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines
-
Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Prostate 1996;29:386-394.
-
(1996)
Prostate
, vol.29
, pp. 386-394
-
-
Webber, M.M.1
Bello, D.2
Quader, S.3
-
8
-
-
0025644325
-
A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
-
Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, Trapman J, Brinkmann AO, Mulder E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun 1990;173:534-540.
-
(1990)
Biochem Biophys Res Commun
, vol.173
, pp. 534-540
-
-
Veldscholte, J.1
Ris-Stalpers, C.2
Kuiper, G.G.3
Jenster, G.4
Berrevoets, C.5
Claassen, E.6
Van Rooij, H.C.7
Trapman, J.8
Brinkmann, A.O.9
Mulder, E.10
-
9
-
-
0018847558
-
The LNCaP cell line - A new model for studies on human prostatic carcinoma
-
Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA. The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980;37:115-132.
-
(1980)
Prog Clin Biol Res
, vol.37
, pp. 115-132
-
-
Horoszewicz, J.S.1
Leong, S.S.2
Chu, T.M.3
Wajsman, Z.L.4
Friedman, M.5
Papsidero, L.6
Kim, U.7
Chai, L.S.8
Kakati, S.9
Arya, S.K.10
Sandberg, A.A.11
-
10
-
-
0037015040
-
The program of androgen-responsive genes in neoplastic prostate epithelium
-
Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 2002;99:11890-11895.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 11890-11895
-
-
Nelson, P.S.1
Clegg, N.2
Arnold, H.3
Ferguson, C.4
Bonham, M.5
White, J.6
Hood, L.7
Lin, B.8
-
11
-
-
0037369090
-
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models
-
Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Prostate 2003;54:249-257.
-
(2003)
Prostate
, vol.54
, pp. 249-257
-
-
Denmeade, S.R.1
Sokoll, L.J.2
Dalrymple, S.3
Rosen, D.M.4
Gady, A.M.5
Bruzek, D.6
Ricklis, R.M.7
Isaacs, J.T.8
-
12
-
-
0032532688
-
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
-
Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 1998;58:4640-4645.
-
(1998)
Cancer Res
, vol.58
, pp. 4640-4645
-
-
Hobisch, A.1
Eder, I.E.2
Putz, T.3
Horninger, W.4
Bartsch, G.5
Klocker, H.6
Culig, Z.7
-
13
-
-
0033583317
-
Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways
-
Sadar MD. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 1999;274:7777-7783.
-
(1999)
J Biol Chem
, vol.274
, pp. 7777-7783
-
-
Sadar, M.D.1
-
14
-
-
0029069878
-
Androgen receptor defects: Historical, clinical, and molecular perspectives
-
Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
-
(1995)
Endocr Rev
, vol.16
, pp. 271-321
-
-
Quigley, C.A.1
De Bellis, A.2
Marschke, K.B.3
El-Awady, M.K.4
Wilson, E.M.5
French, F.S.6
-
15
-
-
0018779369
-
Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
-
Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
-
(1979)
Invest Urol
, vol.17
, pp. 16-23
-
-
Kaighn, M.E.1
Narayan, K.S.2
Ohnuki, Y.3
Lechner, J.F.4
Jones, L.W.5
-
16
-
-
0025045495
-
Androgen receptor gene expression in human prostate carcinoma cell lines
-
Tilley WD, Wilson CM, Marcelli M, McPhaul MJ. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 1990;50:5382-5386.
-
(1990)
Cancer Res
, vol.50
, pp. 5382-5386
-
-
Tilley, W.D.1
Wilson, C.M.2
Marcelli, M.3
McPhaul, M.J.4
-
17
-
-
0035872438
-
Defects of DNA mismatch repair in human prostate cancer
-
Chen Y, Wang J, Fraig MM, Metcalf J, Turner WR, Bissada NK, Watson DK, Schweinfest CW. Defects of DNA mismatch repair in human prostate cancer. Cancer Res 2001;61:4112-4121.
-
(2001)
Cancer Res
, vol.61
, pp. 4112-4121
-
-
Chen, Y.1
Wang, J.2
Fraig, M.M.3
Metcalf, J.4
Turner, W.R.5
Bissada, N.K.6
Watson, D.K.7
Schweinfest, C.W.8
-
18
-
-
0029054750
-
Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3
-
Borner MM, Myers CE, Sartor O, Sei Y, Toko T, Trepel JB, Schneider E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 1995;55:2122-2128.
-
(1995)
Cancer Res
, vol.55
, pp. 2122-2128
-
-
Borner, M.M.1
Myers, C.E.2
Sartor, O.3
Sei, Y.4
Toko, T.5
Trepel, J.B.6
Schneider, E.7
-
19
-
-
0034904913
-
Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells
-
Beresford SA, Davies MA, Gallick GE, Donato NJ. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells. J Interferon Cytokine Res 2001;21:313-322.
-
(2001)
J Interferon Cytokine Res
, vol.21
, pp. 313-322
-
-
Beresford, S.A.1
Davies, M.A.2
Gallick, G.E.3
Donato, N.J.4
-
20
-
-
0030936323
-
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
-
Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947.
-
(1997)
Science
, vol.275
, pp. 1943-1947
-
-
Li, J.1
Yen, C.2
Liaw, D.3
Podsypanina, K.4
Bose, S.5
Wang, S.I.6
Puc, J.7
Miliaresis, C.8
Rodgers, L.9
McCombie, R.10
Bigner, S.H.11
Giovanella, B.C.12
Ittmann, M.13
Tycko, B.14
Hibshoosh, H.15
Wigler, M.H.16
Parsons, R.17
-
21
-
-
0032126505
-
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts
-
Vlietstra RJ, van Alewijk DC, Hermans KG, Van Steenbrugge GJ, Trapman J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 1998;58:2720-2723.
-
(1998)
Cancer Res
, vol.58
, pp. 2720-2723
-
-
Vlietstra, R.J.1
Van Alewijk, D.C.2
Hermans, K.G.3
Van Steenbrugge, G.J.4
Trapman, J.5
-
22
-
-
0034816689
-
DNA mismatch repair enzyme activity and gene expression in prostate cancer
-
Yeh CC, Lee C, Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem Biophys Res Commun 2001;285:409-413.
-
(2001)
Biochem Biophys Res Commun
, vol.285
, pp. 409-413
-
-
Yeh, C.C.1
Lee, C.2
Dahiya, R.3
-
23
-
-
0028245328
-
p53 in prostate cancer: Frequent expressed transition mutations
-
Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. p53 in prostate cancer: Frequent expressed transition mutations. J Natl Cancer Inst 1994;86:926-933.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 926-933
-
-
Chi, S.G.1
DeVere White, R.W.2
Meyers, F.J.3
Siders, D.B.4
Lee, F.5
Gumerlock, P.H.6
-
24
-
-
0028215671
-
Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer
-
Dinjens WN, van der Weiden MM, Schroeder FH, Bosman FT, Trapman J. Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int J Cancer 1994;56:630-633.
-
(1994)
Int J Cancer
, vol.56
, pp. 630-633
-
-
Dinjens, W.N.1
Van Der Weiden, M.M.2
Schroeder, F.H.3
Bosman, F.T.4
Trapman, J.5
-
26
-
-
0030875693
-
Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors [see comments]
-
Hobisch A, Hittmair A, Daxenbichler G, Wille S, Radmayr C, Hobisch-Hagen P, Bartsch G, Klocker H, Culig Z. Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors [see comments]. J Pathol 1997;182:356-361.
-
(1997)
J Pathol
, vol.182
, pp. 356-361
-
-
Hobisch, A.1
Hittmair, A.2
Daxenbichler, G.3
Wille, S.4
Radmayr, C.5
Hobisch-Hagen, P.6
Bartsch, G.7
Klocker, H.8
Culig, Z.9
-
27
-
-
0025636497
-
The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines
-
Trapman J, Ris-Stalpers C, van der Korput JA, Kuiper GG, Faber PW, Romijn JC, Mulder E, Brinkmann AO. The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines. J Steroid Biochem Mol Biol 1990;37:837-842.
-
(1990)
J Steroid Biochem Mol Biol
, vol.37
, pp. 837-842
-
-
Trapman, J.1
Ris-Stalpers, C.2
Van Der Korput, J.A.3
Kuiper, G.G.4
Faber, P.W.5
Romijn, J.C.6
Mulder, E.7
Brinkmann, A.O.8
-
28
-
-
0028966850
-
Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3
-
Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ. Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3. Steroids 1995;60:180-186.
-
(1995)
Steroids
, vol.60
, pp. 180-186
-
-
Tilley, W.D.1
Bentel, J.M.2
Aspinall, J.O.3
Hall, R.E.4
Horsfall, D.J.5
-
29
-
-
0027463844
-
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction
-
Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 1993;22:11-22.
-
(1993)
Prostate
, vol.22
, pp. 11-22
-
-
Culig, Z.1
Klocker, H.2
Eberle, J.3
Kaspar, F.4
Hobisch, A.5
Cronauer, M.V.6
Bartsch, G.7
-
30
-
-
0027990798
-
Detection of human androgen receptor mRNA expression abnormalities by competitive PCR
-
Edelstein RA, Carr MC, Caesar R, Young M, Atala A, Freeman MR. Detection of human androgen receptor mRNA expression abnormalities by competitive PCR. DNA Cell Biol 1994;13:265-273.
-
(1994)
DNA Cell Biol
, vol.13
, pp. 265-273
-
-
Edelstein, R.A.1
Carr, M.C.2
Caesar, R.3
Young, M.4
Atala, A.5
Freeman, M.R.6
-
31
-
-
0033667389
-
Expression of estrogen receptor alpha and beta mRNAs in prostate cancers treated with leuprorelin acetate
-
Maruyama S, Fujimoto N, Asano K, Ito A, Usui T. Expression of estrogen receptor alpha and beta mRNAs in prostate cancers treated with leuprorelin acetate. Eur Urol 2000;38:635-639.
-
(2000)
Eur Urol
, vol.38
, pp. 635-639
-
-
Maruyama, S.1
Fujimoto, N.2
Asano, K.3
Ito, A.4
Usui, T.5
-
32
-
-
0034126666
-
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation
-
Lau KM, LaSpina M, Long J, Ho SM. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000;60:3175-3182.
-
(2000)
Cancer Res
, vol.60
, pp. 3175-3182
-
-
Lau, K.M.1
LaSpina, M.2
Long, J.3
Ho, S.M.4
-
33
-
-
0032403081
-
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells
-
Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res 1998;58:5310-5314.
-
(1998)
Cancer Res
, vol.58
, pp. 5310-5314
-
-
Jarrard, D.F.1
Kinoshita, H.2
Shi, Y.3
Sandefur, C.4
Hoff, D.5
Meisner, L.F.6
Chang, C.7
Herman, J.G.8
Isaacs, W.B.9
Nassif, N.10
-
34
-
-
0035313645
-
Androgen receptor expression in androgen-independent prostate cancer cell lines
-
Chlenski A, Nakashiro K, Ketels KV, Korovaitseva GI, Oyasu R. Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate 2001;47:66-75.
-
(2001)
Prostate
, vol.47
, pp. 66-75
-
-
Chlenski, A.1
Nakashiro, K.2
Ketels, K.V.3
Korovaitseva, G.I.4
Oyasu, R.5
-
35
-
-
0027407539
-
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA
-
Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res 1993;53:1304-1311.
-
(1993)
Cancer Res
, vol.53
, pp. 1304-1311
-
-
Yuan, S.1
Trachtenberg, J.2
Mills, G.B.3
Brown, T.J.4
Xu, F.5
Keating, A.6
-
36
-
-
0031024251
-
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
-
Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP, Brown TJ. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 1997;126:59-73.
-
(1997)
Mol Cell Endocrinol
, vol.126
, pp. 59-73
-
-
Heisler, L.E.1
Evangelou, A.2
Lew, A.M.3
Trachtenberg, J.4
Elsholtz, H.P.5
Brown, T.J.6
-
37
-
-
0026670649
-
Clinical review 37: Endocrine treatment of prostate cancer
-
Santen RJ. Clinical review 37: Endocrine treatment of prostate cancer. J Clin Endocrinol Metab 1992;75:685-689.
-
(1992)
J Clin Endocrinol Metab
, vol.75
, pp. 685-689
-
-
Santen, R.J.1
-
38
-
-
0022445670
-
Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
-
Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
-
(1986)
J Immunol Methods
, vol.89
, pp. 271-277
-
-
Denizot, F.1
Lang, R.2
-
40
-
-
0033978514
-
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
-
Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, Coetzee GA. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 2000;9:267-274.
-
(2000)
Hum Mol Genet
, vol.9
, pp. 267-274
-
-
Irvine, R.A.1
Ma, H.2
Yu, M.C.3
Ross, R.K.4
Stallcup, M.R.5
Coetzee, G.A.6
-
41
-
-
0034520311
-
A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo
-
Zhang J, Thomas TZ, Kasper S, Matusik RJ. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000;141:4698-4710.
-
(2000)
Endocrinology
, vol.141
, pp. 4698-4710
-
-
Zhang, J.1
Thomas, T.Z.2
Kasper, S.3
Matusik, R.J.4
-
42
-
-
17744378148
-
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function
-
Buchanan G, Yang M, Nahm SJ, Han G, Moore N, Bentel JM, Matusik RJ, Horsfall DJ, Marshall VR, Greenberg NM, Tilley WD. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Mol Endocrinol 2000;15:46-56.
-
(2000)
Mol Endocrinol
, vol.15
, pp. 46-56
-
-
Buchanan, G.1
Yang, M.2
Nahm, S.J.3
Han, G.4
Moore, N.5
Bentel, J.M.6
Matusik, R.J.7
Horsfall, D.J.8
Marshall, V.R.9
Greenberg, N.M.10
Tilley, W.D.11
-
43
-
-
0033988524
-
Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells
-
Zhang S, Wear DJ, Lo S. Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol 2000;27:43-50.
-
(2000)
FEMS Immunol Med Microbiol
, vol.27
, pp. 43-50
-
-
Zhang, S.1
Wear, D.J.2
Lo, S.3
-
46
-
-
0034491081
-
Mycoplasma detection in cell cultures: A comparison of four methods
-
Garner CM, Hubbold LM, Chakraborti PR. Mycoplasma detection in cell cultures: A comparison of four methods. Br J Biomed Sci 2000;57:295-301.
-
(2000)
Br J Biomed Sci
, vol.57
, pp. 295-301
-
-
Garner, C.M.1
Hubbold, L.M.2
Chakraborti, P.R.3
-
47
-
-
0343067144
-
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
-
Pan Y, Kytola S, Farnebo F, Wang N, Lui WO, Nupponen N, Isola J, Visakorpi T, Bergerheim US, Larsson C. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping. Cytogenet Cell Genet 1999;87:225-232.
-
(1999)
Cytogenet Cell Genet
, vol.87
, pp. 225-232
-
-
Pan, Y.1
Kytola, S.2
Farnebo, F.3
Wang, N.4
Lui, W.O.5
Nupponen, N.6
Isola, J.7
Visakorpi, T.8
Bergerheim, U.S.9
Larsson, C.10
-
48
-
-
0025311931
-
Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate
-
Husmann DA, Wilson CM, McPhaul MJ, Tilley WD, Wilson JD. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 1990;126:2359-2368.
-
(1990)
Endocrinology
, vol.126
, pp. 2359-2368
-
-
Husmann, D.A.1
Wilson, C.M.2
McPhaul, M.J.3
Tilley, W.D.4
Wilson, J.D.5
-
49
-
-
0030949836
-
GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
-
Hong H, Kohli K, Garabedian MJ, Stallcup MR. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 1997;17:2735-2744.
-
(1997)
Mol Cell Biol
, vol.17
, pp. 2735-2744
-
-
Hong, H.1
Kohli, K.2
Garabedian, M.J.3
Stallcup, M.R.4
-
50
-
-
0033955282
-
Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors
-
Huang SM, Stallcup MR. Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors. Mol Cell Biol 2000;20:1855-1867.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 1855-1867
-
-
Huang, S.M.1
Stallcup, M.R.2
-
51
-
-
3943110019
-
Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT
-
Liao G, Chen LY, Zhang A, Godavarthy A, Xia F, Ghosh JC, Li H, Chen JD. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J Biol Chem 2002.
-
(2002)
J Biol Chem
-
-
Liao, G.1
Chen, L.Y.2
Zhang, A.3
Godavarthy, A.4
Xia, F.5
Ghosh, J.C.6
Li, H.7
Chen, J.D.8
-
52
-
-
0036218774
-
The amino terminus of the human AR is target for corepressor action and antihormone agonism
-
Dotzlaw H, Moehren U, Mink S, Cato AC, Iniguez Lluhi JA, Baniahmad A. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Mol Endocrinol 2002;16:661-673.
-
(2002)
Mol Endocrinol
, vol.16
, pp. 661-673
-
-
Dotzlaw, H.1
Moehren, U.2
Mink, S.3
Cato, A.C.4
Iniguez Lluhi, J.A.5
Baniahmad, A.6
-
53
-
-
0036219918
-
Androgen receptor (AR) coregulators: An overview
-
Heinlein CA, Chang C. Androgen receptor (AR) coregulators: An overview. Endocr Rev 2002;23:175-200.
-
(2002)
Endocr Rev
, vol.23
, pp. 175-200
-
-
Heinlein, C.A.1
Chang, C.2
-
54
-
-
0034327357
-
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
-
Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Res 2000;60:5946-5949.
-
(2000)
Cancer Res
, vol.60
, pp. 5946-5949
-
-
Park, J.J.1
Irvine, R.A.2
Buchanan, G.3
Koh, S.S.4
Park, J.M.5
Tilley, W.D.6
Stallcup, M.R.7
Press, M.F.8
Coetzee, G.A.9
-
55
-
-
0033583033
-
Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate
-
Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A, Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Biol Chem 1999;274:8316-8321.
-
(1999)
J Biol Chem
, vol.274
, pp. 8316-8321
-
-
Fujimoto, N.1
Yeh, S.2
Kang, H.Y.3
Inui, S.4
Chang, H.C.5
Mizokami, A.6
Chang, C.7
-
56
-
-
0035361340
-
A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy
-
Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, Wilson EM. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001;61:4315-4319.
-
(2001)
Cancer Res
, vol.61
, pp. 4315-4319
-
-
Gregory, C.W.1
He, B.2
Johnson, R.T.3
Ford, O.H.4
Mohler, J.L.5
French, F.S.6
Wilson, E.M.7
-
57
-
-
3943079773
-
Androgen receptor signaling in prostate cancer
-
Henderson BE, Ponder BA, Ross RK, editors. New York: Oxford University Press
-
Tilley WD, Buchanan G, Coetzee GA. Androgen receptor signaling in prostate cancer. In: Henderson BE, Ponder BA, Ross RK, editors. Hormones genes and cancer. New York: Oxford University Press; 2003. pp 288-315.
-
(2003)
Hormones Genes and Cancer
, pp. 288-315
-
-
Tilley, W.D.1
Buchanan, G.2
Coetzee, G.A.3
-
58
-
-
0036645414
-
Molecular biology of the androgen receptor
-
Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002;20:3001-3015.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3001-3015
-
-
Gelmann, E.P.1
-
60
-
-
0037187408
-
Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer
-
Matias PM, Carrondo MA, Coelho R, Thomaz M, Zhao XY, Wegg A, Crusius K, Egner U, Donner P. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer. J Med Chem 2002;45:1439-1446.
-
(2002)
J Med Chem
, vol.45
, pp. 1439-1446
-
-
Matias, P.M.1
Carrondo, M.A.2
Coelho, R.3
Thomaz, M.4
Zhao, X.Y.5
Wegg, A.6
Crusius, K.7
Egner, U.8
Donner, P.9
-
61
-
-
0034714276
-
Structural evidence for ligand specificity in the binding domain of the human Androgen receptor: Implications for pathogenic gene mutations
-
Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A, Basler S, Schafer M, Egner U, Carrondo MA. Structural evidence for ligand specificity in the binding domain of the human Androgen receptor: Implications for pathogenic gene mutations. J Biol Chem 2000;275:26164-26171.
-
(2000)
J Biol Chem
, vol.275
, pp. 26164-26171
-
-
Matias, P.M.1
Donner, P.2
Coelho, R.3
Thomaz, M.4
Peixoto, C.5
Macedo, S.6
Otto, N.7
Joschko, S.8
Scholz, P.9
Wegg, A.10
Basler, S.11
Schafer, M.12
Egner, U.13
Carrondo, M.A.14
-
62
-
-
0035942197
-
Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone
-
Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR, Weinmann R, Einspahr HM. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 2001;98:4904-4909.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 4904-4909
-
-
Sack, J.S.1
Kish, K.F.2
Wang, C.3
Attar, R.M.4
Kiefer, S.E.5
An, Y.6
Wu, G.Y.7
Scheffler, J.E.8
Salvati, M.E.9
Krystek, S.R.10
Weinmann, R.11
Einspahr, H.M.12
-
63
-
-
0035815749
-
Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer
-
Han G, Foster BA, Mistry S, Buchanan G, Harris JM, Tilley WD, Greenberg NM. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem 2001;276:11204-11213.
-
(2001)
J Biol Chem
, vol.276
, pp. 11204-11213
-
-
Han, G.1
Foster, B.A.2
Mistry, S.3
Buchanan, G.4
Harris, J.M.5
Tilley, W.D.6
Greenberg, N.M.7
-
64
-
-
0037470194
-
Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment
-
Thin TH, Wang L, Kim E, Collins LL, Basavappa R, Chang C. Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment. J Biol Chem 2003;278:7699-7708.
-
(2003)
J Biol Chem
, vol.278
, pp. 7699-7708
-
-
Thin, T.H.1
Wang, L.2
Kim, E.3
Collins, L.L.4
Basavappa, R.5
Chang, C.6
-
65
-
-
0032883932
-
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
-
Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer 1999;81:242-251.
-
(1999)
Br J Cancer
, vol.81
, pp. 242-251
-
-
Culig, Z.1
Hoffmann, J.2
Erdel, M.3
Eder, I.E.4
Hobisch, A.5
Hittmair, A.6
Bartsch, G.7
Utermann, G.8
Schneider, M.R.9
Parczyk, K.10
Klocker, H.11
-
66
-
-
0034483236
-
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line
-
Festuccia C, Gravina GL, Angelucci A, Millimaggi D, Bologna M. Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line. Anticancer Res 2000;20:4367-4371.
-
(2000)
Anticancer Res
, vol.20
, pp. 4367-4371
-
-
Festuccia, C.1
Gravina, G.L.2
Angelucci, A.3
Millimaggi, D.4
Bologna, M.5
-
67
-
-
0034675275
-
Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels
-
Sheflin L, Keegan B, Zhang W, Spaulding SW. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun 2000;276:144-150.
-
(2000)
Biochem Biophys Res Commun
, vol.276
, pp. 144-150
-
-
Sheflin, L.1
Keegan, B.2
Zhang, W.3
Spaulding, S.W.4
-
68
-
-
0035880637
-
A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects
-
Beilin J, Harewood L, Frydenberg M, Mameghan H, Martyres RF, Farish SJ, Yue C, Deam DR, Byron KA, Zajac JD. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer 2001;92:941-949.
-
(2001)
Cancer
, vol.92
, pp. 941-949
-
-
Beilin, J.1
Harewood, L.2
Frydenberg, M.3
Mameghan, H.4
Martyres, R.F.5
Farish, S.J.6
Yue, C.7
Deam, D.R.8
Byron, K.A.9
Zajac, J.D.10
-
69
-
-
0026587321
-
Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic, and neoplastic human prostate
-
Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic, and neoplastic human prostate. J Urol 1992;147:798-803.
-
(1992)
J Urol
, vol.147
, pp. 798-803
-
-
Chodak, G.W.1
Kranc, D.M.2
Puy, L.A.3
Takeda, H.4
Johnson, K.5
Chang, C.6
-
70
-
-
0028111565
-
Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis
-
Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: Measurement by color video image analysis. Cancer Res 1994;54:4096-4102.
-
(1994)
Cancer Res
, vol.54
, pp. 4096-4102
-
-
Tilley, W.D.1
Lim-Tio, S.S.2
Horsfall, D.J.3
Aspinall, J.O.4
Marshall, V.R.5
Skinner, J.M.6
-
71
-
-
0030758487
-
Heterogeneity of androgen receptor content in advanced prostate cancer
-
Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pathol 1997;10:839-845.
-
(1997)
Mod Pathol
, vol.10
, pp. 839-845
-
-
Magi-Galluzzi, C.1
Xu, X.2
Hlatky, L.3
Hahnfeldt, P.4
Kaplan, I.5
Hsiao, P.6
Chang, C.7
Loda, M.8
-
72
-
-
0027536495
-
Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy
-
Sadi MV, Barrack ER. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer 1993;71:2574-2580.
-
(1993)
Cancer
, vol.71
, pp. 2574-2580
-
-
Sadi, M.V.1
Barrack, E.R.2
-
73
-
-
0035300409
-
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen
-
Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res 2001;61:2892-2898.
-
(2001)
Cancer Res
, vol.61
, pp. 2892-2898
-
-
Gregory, C.W.1
Johnson, R.T.2
Mohler, J.L.3
French, F.S.4
Wilson, E.M.5
-
74
-
-
0036141411
-
Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft
-
Kim D, Gregory CW, French FS, Smith GJ, Mohler JL. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am J Pathol 2002;160:219-226.
-
(2002)
Am J Pathol
, vol.160
, pp. 219-226
-
-
Kim, D.1
Gregory, C.W.2
French, F.S.3
Smith, G.J.4
Mohler, J.L.5
-
75
-
-
0036219874
-
Mechanisms involved in the progression of androgen-independent prostate cancers: It is not only the cancer cell's fault
-
Arnold JT, Isaacs JJ. Mechanisms involved in the progression of androgen-independent prostate cancers: It is not only the cancer cell's fault. Endocr Relat Cancer 2002;9:61-73.
-
(2002)
Endocr Relat Cancer
, vol.9
, pp. 61-73
-
-
Arnold, J.T.1
Isaacs, J.J.2
-
76
-
-
0041633910
-
Interrogating androgen receptor function in recurrent prostate cancer
-
Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M, Gambhir SS, Wu L, Carey M. Interrogating androgen receptor function in recurrent prostate cancer. Cancer Res 2003;63:4552-4560.
-
(2003)
Cancer Res
, vol.63
, pp. 4552-4560
-
-
Zhang, L.1
Johnson, M.2
Le, K.H.3
Sato, M.4
Ilagan, R.5
Iyer, M.6
Gambhir, S.S.7
Wu, L.8
Carey, M.9
|